(Q44016826)

29 November 2017

title

Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes (English)

1 reference

29 November 2017

Kenji Nagata

1

1 reference

29 November 2017

Toshiyuki Ishibashi

2

1 reference

29 November 2017

Takayuki Sakamoto

3

1 reference

29 November 2017

Hiroshi Ohkawara

4

1 reference

29 November 2017

Joji Shindo

5

1 reference

29 November 2017

Keiko Yokoyama

6

1 reference

29 November 2017

Koichi Sugimoto

7

1 reference

29 November 2017

Sotaro Sakurada

8

1 reference

29 November 2017

Yoh Takuwa

9

1 reference

29 November 2017

Shin Nakamura

10

1 reference

29 November 2017

Tamio Teramoto

11

1 reference

29 November 2017

Yukio Maruyama

12

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

163

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

39-47

1 reference

The coagulation cascade: initiation, maintenance, and regulation

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Are we mortgaging the medical profession?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Tissue-factor antigen and activity in human coronary atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Tissue factor expression on macrophages in coronary plaques in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Tissue factor in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Increased monocyte tissue factor expression in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Role of macrophage tissue factor in the development of the delayed hypersensitivity reaction in monkey skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Monocyte thromboplastin (tissue factor): complementary effect of lymphocytes upon its generation by endotoxin-stimulated monkey (Macaca fuscata) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900750-X

10.1016/S0021-9150(01)00750-X

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference